Page last updated: 2024-08-17

zoxazolamine and Hyperplasia

zoxazolamine has been researched along with Hyperplasia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, YW; Ge, K; Gonzalez, FJ; Guo, D; Guo, GL; Jia, Y; Kashireddi, P; Kemper, B; Qi, C; Rao, MS; Reddy, JK; Sarkar, J; Surapureddi, S; Xia, J; Yu, S	1

Other Studies

1 other study(ies) available for zoxazolamine and Hyperplasia

Article	Year
Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity. Proceedings of the National Academy of Sciences of the United States of America, 2005, Aug-30, Volume: 102, Issue:35 Topics: Acetaminophen; Animals; Base Sequence; Constitutive Androstane Receptor; DNA; Gene Expression; Hyperplasia; Hypertrophy; Liver; Mediator Complex Subunit 1; Mice; Mice, Knockout; Muscle Relaxants, Central; Paralysis; Peroxisome Proliferator-Activated Receptors; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Zoxazolamine	2005

Article

Year

Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity.

Proceedings of the National Academy of Sciences of the United States of America, 2005, Aug-30, Volume: 102, Issue:35

Topics: Acetaminophen; Animals; Base Sequence; Constitutive Androstane Receptor; DNA; Gene Expression; Hyperplasia; Hypertrophy; Liver; Mediator Complex Subunit 1; Mice; Mice, Knockout; Muscle Relaxants, Central; Paralysis; Peroxisome Proliferator-Activated Receptors; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Zoxazolamine

2005